Patents
Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
03/2012
03/15/2012WO2012033061A1 Organic electroluminescent element and charge transport material
03/15/2012WO2012032990A1 Photoelectric conversion material, film containing material, photoelectric conversion element, method for producing photoelectric conversion element, method of using photoelectric conversion element, photosensor and image sensor
03/15/2012WO2012031534A1 1,2,3,4,5,6,7,8-octohydro-9-phenylacetamidoacridine, preparation method and pharmaceutical use thereof
03/15/2012DE102010045405A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
03/08/2012WO2012029253A1 Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using same
02/2012
02/23/2012WO2012024670A2 Composition and methods for treating glioblastoma
02/21/2012US8119422 Stable acridinium esters with fast light emission
02/14/2012US8115027 NPY Y5 antagonist
02/07/2012US8110562 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof
02/02/2012CA2804355A1 Novel microbiocidal dioxime ether derivatives
01/2012
01/31/2012US8106203 Assay methods using chemiluminescent detection of peroxidase
01/26/2012WO2011127406A3 Acridines as inhibitors of haspin and dyrk kinases
01/26/2012US20120020893 Intravascular Imaging Device and Uses Thereof
01/19/2012US20120015373 Acridone derivatives as labels for fluorescence detection of target materials
01/19/2012DE102010027218A1 Organische Komplexe enthaltend Metalle Organic complexes containing metals
01/18/2012CN102321021A Purification method of 10-ethyl acridone-2-sulfonyl chloride
12/2011
12/22/2011WO2011156889A1 Novel modulators of nrf2 and uses thereof
12/20/2011CA2449201C Acridone derivatives as labels for fluorescence detection of target materials
12/15/2011WO2011155169A1 Compounds with acridan ring structures and organic electroluminescence elements
11/2011
11/24/2011US20110288292 Materials for organic electroluminescence devices
11/23/2011CN102249999A Fluorine-containing acridones compound and preparation method thereof
11/17/2011US20110281907 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
11/15/2011US8057990 Prevent, therapy for cancer; complex of tacrine compound and protein
11/03/2011US20110266533 Compounds for electronic devices
11/02/2011CN102229602A Tacrine heterocomplex, preparation method and use in medicines for curing neurodegenerative diseases thereof
11/02/2011CN102229565A Spirofluorene bisbenzoacridine organic semiconductor material, preparation method and use method thereof
10/2011
10/26/2011EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011CN102227486A Organic electroluminscent device using electroluminescent compounds
10/19/2011CN102219740A 1,2,3,4,5,6,7,8-octahydro-9-phenylacetamide acridine as well as preparation method and medicinal application thereof
10/19/2011CN102219739A Azaanthracene compound and synthesizing method thereof
10/13/2011WO2011127406A2 Acridines as inhibitors of haspin and dyrk kinases
10/13/2011WO2011123911A1 Antitumoral compounds of testosterone and chemotherapeutic drugs
10/13/2011US20110250699 Fluorescent Dye Compounds, Conjugates and Uses Thereof
10/11/2011US8034636 Hydrophilic chemiluminescent acridinium labeling reagents
10/11/2011US8034558 Acridone derivatives as labels for fluorescence detection of target materials
10/05/2011EP2371927A1 Fluorescent dye compounds, conjugates and uses thereof
10/04/2011USRE42802 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
09/2011
09/28/2011CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/28/2011CN102203066A Novel dyes and use thereof in imaging members and methods
09/14/2011EP2365735A2 Luminescent element material and luminescent element comprising the same
09/14/2011EP1809288B1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
09/07/2011EP2363399A1 Labelled analogues of halobenzamides as radiopharmaceuticals
09/01/2011WO2011105700A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/01/2011WO2011070177A3 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
08/2011
08/18/2011WO2011099606A1 Photoelectric element and imaging device and driving methods therefor
08/17/2011EP2357176A1 Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
08/10/2011CN102146056A N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives
08/04/2011WO2011093603A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/03/2011EP2350013A2 Compositions for labeling and identifying autophagosomes and methods for making and using them
08/02/2011CA2479109C Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
07/2011
07/28/2011DE102010005697A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices
07/27/2011CN102134220A 9-amsacrine derivatives as well as preparation method and application thereof
07/21/2011WO2011086178A1 Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
07/21/2011US20110177105 Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their Therapeutic Applications
07/21/2011CA2786957A1 Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
06/2011
06/28/2011US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection
06/16/2011WO2011070177A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
06/16/2011CA2783934A1 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
05/2011
05/26/2011WO2011062182A1 Aromatic sulfonium salt compound
05/19/2011WO2011060228A1 Zwitterion-containing acridinium compounds
05/18/2011CN102060766A 2-iodine-12-phenyl benz[b]acridine-6, 11-diketone and synthesis method thereof
05/17/2011US7943630 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
05/11/2011CN102050782A Preparation method of spirofluorene acridine intermediate
05/10/2011CA1341613C Assays utilizing improved chemiluminescent esters, thioesters and amides
05/05/2011WO2011051950A1 9-aminoacridine derivatives, their preparation and uses
05/05/2011US20110105554 Means for treating myosin-related diseases
05/04/2011CN101585808B Method for asymmetric catalytic hydrogenation of quinoline derivatives
05/03/2011CA2400394C 9-alkylamino-1-nitroacridine derivatives
04/2011
04/26/2011CA2500952C Neurologically-active compounds
04/20/2011CN102024907A Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods
04/14/2011WO2010147319A3 Acridine derivative and an organic electroluminescent element comprising the same
03/2011
03/31/2011US20110077221 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof
03/30/2011CN101279969B Organic electroluminescent material and application thereof
03/24/2011WO2011034071A1 Process for production of oxidation reaction product of aromatic compound
03/22/2011US7910754 Colorant compounds
03/22/2011US7910739 tacrine derivatives such as N-[5(6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)pentyl]-3-(1H-indol-3-yl) propionamide, used for treatment of neurodegenerative diseases; bioassays
03/16/2011CN101525392B 9-phenylacridine photoinitiator and preparation method thereof
03/15/2011US7906235 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
02/2011
02/17/2011US20110039802 Npy y5 antagonist
02/17/2011US20110039289 Fluorogenic peptides and their method of production
02/15/2011US7888509 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors
01/2011
01/25/2011US7875467 Chemiluminescence; quantitative analysis of macromolecules; complexing sample to acridinium compound, labels for improving sensitivity of immunoassays, 2',6'-dimethyl-4'-N-succinimidyloxycaproyl-amidocarbonylphenyl-N10-2,7-tris[O-methoxyhexa(ethylene) glycol-sulfonamidylpropyl]-acridinium-9-carboxylate
01/20/2011US20110014721 Hydrophilic chemiluminescent acridinium labeling reagents
01/13/2011US20110009293 Nonseparation Assay Methods
01/11/2011CA2430606C Dyeing or printing of manufactured natural polymer and synthetic hydrophobic fibre materials
01/06/2011US20110003992 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors
01/05/2011EP2268608A2 Stabilized nucleic acid dark quencher-fluorophore probes
01/05/2011DE102009031021A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
12/2010
12/29/2010WO2010151006A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/29/2010EP2265117A1 Inhibitors of protein phosphatase-1 and uses thereof
12/29/2010EP1292573B1 Substituted thioacetamides
12/23/2010WO2010147319A2 Acridine derivative and an organic electroluminescent element comprising the same
12/23/2010WO2010145696A1 Methods for detecting the presence or absence of blood
12/15/2010CN101918367A Facile N-alkylation of acridine compounds in ionic liquids
12/15/2010CN101914060A Synthesis of polyhydroacridine derivatives by clean catalysis of degradable ionic liquid
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2159546C Cycloalkano-indole and -azaindole derivatives
12/08/2010CN1482691B Display device with anthracene and triazine derivatives
12/01/2010CN101898982A Npy y5 antagonists
11/2010
11/25/2010US20100297762 Photodynamic therapy using chemiluminescence and a ligand-photosensitiser conjugate
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 22